ReWalk exoskeleton shows near-zero fracture rates over six years, boosting safety confidence for spinal injury mobility.

Lifeward Ltd. presented new data at the ASIA 2026 conference showing that the ReWalk powered exoskeleton has a very low fracture rate, with only 3% lifetime prevalence globally since 2013 and just 0.3% in the last six years. Notably, no fractures were reported among 97 German users since 2018, despite diverse patient profiles. These findings highlight significant safety improvements due to better device design and training, supporting wider adoption of ReWalk for spinal cord injury rehabilitation. The data reinforce ReWalk's role as a safe and effective mobility aid for people with spinal cord injuries.